CRYBA1 - N-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-CRYBA1 - N-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCRYBA1 - N-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, guinea pig, horse, human, mouse, rabbit, rat, zebrafish
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against CRYBA1. It was validated on Western Blot using a cell lysate as a positive control.Target Description: Crystallins are the dominant structural components of the vertebrate eye lens. Defects in CRYBA1 are the cause of congenital zonular cataract with sutural opacities (CCZS).Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins ar
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human CRYBA1
Other Names[beta-crystallin A3; Beta-crystallin A3; beta-crystallin A3; crystallin beta A1]
Gene, Accession #[CRYBA1], Gene ID: 1411, NCBI: NP_005199, UniProt: P05813
Catalog #MBS3210582
Price$335
Order / More InfoCRYBA1 - N-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.